Skip to content
← All ETFs
XLV

Health Care Select Sector SPDR Fund

Tracks the Health Care Select Sector Index, covering US pharmaceutical, biotech, medical device, and healthcare services companies. Includes UnitedHealth, Johnson & Johnson, and Eli Lilly. Defensive sector with long-term growth potential.

EquityTER 0.09%Dist.
TER
0.09%
AUM
$41B
CAGR
8.0%
Volatility
14.3%
Sharpe
0.35
Max Drawdown
-35.5%
Data Range
1999-01 → 2026-04

Performance Analysis

Maximum Drawdown History

How far the ETF has fallen from its all-time high at each point. Deeper = more painful.

Current DD-7.4%
Worst DD-35.5%
Worst date2009-02

Rolling Returns

Annualized returns over rolling windows. Shows the range of outcomes depending on when you invested.

Avg return8.8%
Best29.6%
Worst-9.4%
% positive86%
292 periods

Key Facts

ISIN
US81369Y2090
Issuer
State Street
Benchmark
Health Care Select Sector Index
Total Expense Ratio (TER)
0.09%
Assets Under Management
$41B approx.
Inception Date
1998-12-16
Domicile
United States
Legal Structure
Open-Ended Fund
Dividend Policy
Distributing (pays dividends)
Replication Method
Physical (Full Replication)
UCITS Status
✗ Not UCITS
Fund Currency
USD
Primary Exchange
NYSE Arca
Number of Holdings
~64

Top 10 Holdings

Top 10 represent 56.5% of the fund.

1
LLYEli Lilly
11.50%
2
UNHUnitedHealth
10.00%
3
JNJJohnson & Johnson
7.00%
4
ABBVAbbVie Inc.
6.50%
5
MRKMerck & Co.
5.00%
6
TMOThermo Fisher
4.20%
7
ABTAbbott Laboratories
3.80%
8
AMGNAmgen Inc.
3.20%
9
PFEPfizer Inc.
2.80%
10
ISRGIntuitive Surgical
2.50%

Sector Breakdown

Pharmaceuticals
38%
Healthcare Equipment
25%
Biotechnology
15%
Healthcare Providers
12%
Life Sciences
10%

Source: Official issuer data · Last updated: 2026-05-12

Backtest this ETFOfficial Fund Page

Who Is This ETF For?

General portfolio building block for the asset class it covers.

Key Risks to Consider

Market risk: equity values can drop 30-50% in severe bear markets.

Non-UCITS: may have unfavorable tax treatment for non-US investors (US estate tax, withholding tax).

Similar ETFs

Continue Your Analysis

Data & Methodology

Metadata sourced from official issuer documentation. Price data from Yahoo Finance (monthly adjusted close, includes reinvested dividends and splits). AUM figures are approximate and updated quarterly.

Data source: Yahoo Finance (adjusted close), State Street (metadata)Last verified: 2026-04-16

Related Guides from FinClaro Chile

Related ETFs

Similar ETFs

SPY

SPDR S&P 500 ETF Trust

TER 0.09%$570B AUM
VOO

Vanguard S&P 500 ETF

TER 0.03%$560B AUM
IVV

iShares Core S&P 500 ETF

TER 0.03%$560B AUM
VTI

Vanguard Total Stock Market ETF

TER 0.03%$435B AUM

Alternative Approaches

QQQ

Invesco QQQ Trust

TER 0.20%$310B AUM
VUG

Vanguard Growth ETF

TER 0.04%$130B AUM
VTV

Vanguard Value ETF

TER 0.04%$130B AUM
IEFA

iShares Core MSCI EAFE ETF

TER 0.07%$125B AUM

💬 Frequently Asked Questions

Tracks the Health Care Select Sector Index, covering US pharmaceutical, biotech, medical device, and healthcare services companies. Includes UnitedHealth, Johnson & Johnson, and Eli Lilly. Defensive sector with long-term growth potential.
XLV has a total expense ratio (TER) of 0.09%, which means you pay $9 per year for every $10,000 invested.
Yes, XLV is a distributing ETF that pays dividends to shareholders. The frequency depends on the fund's schedule.
XLV is a US-domiciled ETF (not UCITS). Non-US investors should consider the US estate tax implications (40% on US assets above $60,000) and the 30% dividend withholding tax (reduced by treaty in some countries).
XLV uses full physical replication, meaning it holds all (or nearly all) securities in the Health Care Select Sector Index index directly.